Jazz Pharmaceuticals (JAZZ) EBT (2010 - 2026)
Jazz Pharmaceuticals' quarterly EBT came in at $299.2 million in Q1 2026, up 372.5% year-on-year from $63.3 million in Q1 2025, and up 43.52% quarter-over-quarter from $208.5 million in Q4 2025.
Jazz Pharmaceuticals has reported EBT for 17 years, with the latest figure at $299.2 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 372.5% year-over-year to $299.2 million; the trailing twelve-month figure through Mar 2026 stood at -$218.8 million (down 160.43% YoY), and the FY2025 full-year result was -$627.9 million, down 233.49% from the prior year.
- EBT for Q1 2026 stood at $299.2 million, up from $208.5 million in the prior quarter.
- The five-year high for EBT was $299.2 million in Q1 2026, with the low at -$735.6 million in Q2 2025.
- Average EBT over 5 years is $3.9 million, with a median of $55.1 million recorded in 2023.
- Year-over-year, EBT soared 771.16% in 2023 and plunged 6753.93% in 2025.
- Tracing JAZZ's EBT over 5 years: stood at -$340.0 million in 2022, then surged by 118.1% to $61.5 million in 2023, then soared by 116.52% to $133.2 million in 2024, then jumped by 56.49% to $208.5 million in 2025, then surged by 43.52% to $299.2 million in 2026.
- The last three EBT figures came in at $299.2 million (Q1 2026), $208.5 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 299.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299.20 Mn |
| Dec 31, 2025 | 208.47 Mn |
| Sep 30, 2025 | 9.04 Mn |
| Jun 30, 2025 | -735.55 Mn |
| Mar 31, 2025 | -109.80 Mn |
| Dec 31, 2024 | 133.22 Mn |
| Sep 30, 2024 | 200.81 Mn |
| Jun 30, 2024 | 137.93 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | 61.53 Mn |
| Sep 30, 2023 | 99.52 Mn |
| Jun 30, 2023 | 81.78 Mn |
| Mar 31, 2023 | 55.10 Mn |
| Dec 31, 2022 | -339.99 Mn |
| Sep 30, 2022 | -60.13 Mn |
| Jun 30, 2022 | 21.01 Mn |
| Mar 31, 2022 | 6.33 Mn |
| Dec 31, 2021 | -44.83 Mn |
| Sep 30, 2021 | -67.63 Mn |
| Jun 30, 2021 | -136.06 Mn |
| Mar 31, 2021 | 135.69 Mn |
| Dec 31, 2020 | 144.81 Mn |
| Sep 30, 2020 | 168.14 Mn |
| Jun 30, 2020 | 171.45 Mn |
| Mar 31, 2020 | -209.30 Mn |
| Dec 31, 2019 | 40.77 Mn |
| Sep 30, 2019 | 114.21 Mn |
| Jun 30, 2019 | 184.12 Mn |
| Mar 31, 2019 | 115.21 Mn |
| Dec 31, 2018 | 165.46 Mn |
| Sep 30, 2018 | 169.10 Mn |
| Jun 30, 2018 | 129.43 Mn |
| Mar 31, 2018 | 65.47 Mn |
| Dec 31, 2017 | 118.93 Mn |
| Sep 30, 2017 | 65.04 Mn |
| Jun 30, 2017 | 141.32 Mn |
| Mar 31, 2017 | 115.83 Mn |
| Dec 31, 2016 | 151.31 Mn |
| Sep 30, 2016 | 116.37 Mn |
| Jun 30, 2016 | 156.61 Mn |
| Mar 31, 2016 | 108.15 Mn |
| Dec 31, 2015 | 96.51 Mn |
| Sep 30, 2015 | 117.91 Mn |
| Jun 30, 2015 | 118.76 Mn |
| Mar 31, 2015 | 102.76 Mn |
| Dec 31, 2014 | 115.24 Mn |
| Sep 30, 2014 | 49.99 Mn |
| Jun 30, 2014 | 62.94 Mn |
| Mar 31, 2014 | -76.61 Mn |
| Sep 30, 2013 | 93.74 Mn |
| Jun 30, 2013 | 65.79 Mn |
| Mar 31, 2013 | 61.06 Mn |
| Dec 31, 2012 | 57.45 Mn |
| Sep 30, 2012 | 46.45 Mn |
| Jun 30, 2012 | 37.71 Mn |
| Mar 31, 2012 | 35.75 Mn |
| Dec 31, 2011 | 37.47 Mn |
| Sep 30, 2011 | 32.48 Mn |
| Jun 30, 2011 | 33.20 Mn |
| Mar 31, 2011 | 21.83 Mn |
| Dec 31, 2010 | 13.38 Mn |
| Sep 30, 2010 | 13.24 Mn |
| Jun 30, 2010 | 10.33 Mn |